Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Paclitaxel 175 / Carboplatin 5 / Bevacizumab 5, Melanoma

Protocol-ID: 2017 V1.0 (Mini), PACL175/CRBP5/BEVA5, Melanoma

Indication(s)

  • Melanoma, Malignant (mucosal); ICD-10 C44.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 27.03.2022